Abstract:Background: Gambogic acid (GA) is a natural product from the resin of the Garcinia species, which showed significant activity in the induction of apoptosis. It can be one promising lead compound for the design and synthesis of new anticancer drugs. Objective: The objective of the current study is to design novel nitrogen-contained GA derivatives with better anti-cancer activities and study the effect of the introduction of different nitrogen-contained groups on the activity of GA. Methods: The designed 15 derivatives were synthesized via esterification or amidation of 30-carboxylate. The synthetic compounds were characterized via different spectroscopic techniques, including X-ray single crystal diffraction, MS and NMR. The cytotoxic activity of the designed derivatives was evaluated in vitro against A549, HepG-2, and MCF-7 cell lines using methyl thiazolyl tetrazolium (MTT) test. Results: 15 nitrogen-contained GA derivatives were successfully synthesized and established. Based on the IC50 values, compounds 9, 10, 11 and 13 showed stronger inhibitory effects on A549, HepG-2, MCF-7 cell lines than GA, while 9 is the most active compound with IC 50 value of 0.64-1.49 μM. Most derivatives of GA with esterification of C-30 including cyano-benzene ring were generally weaker than those of pyrimidinyl-substituted derivatives. In addition, length of alkyl linkers between C-30 of GA and nitrogen-contained group produced different effects on A549, HepG-2 and MCF-7 cell lines. Conclusion: The structure-activity relationship results show that aromatic substituent and linker length play important roles to improve the anticancer activities, while compound 9 with pyrimidine substituent and C-C-C linkers is the most active derivative against tested cell lines, and is a promising anti-cancer agent for further development.

Studies on Chemical‐Structure Modification and StructureActivity Relationship of Gambogic Acid Derivatives at Carbon(34)

Studies on Chemical Structure Modification and Structure?Activity Relationship of Derivatives of Gambogic Acid at C(39)

Synthesis and Anti-Tumor Evaluation of Novel C-37 Modified Derivatives of Gambogic Acid

Studies on chemical structure modification and biology of a natural product, gambogic acid (I): Synthesis and biological evaluation of oxidized analogues of gambogic acid.

Synthesis and Evaluation of Gambogic Acid Derivatives As Antitumor Agents. Part III.

Studies on chemical modification and biology of a natural product, gambogic acid (II): Synthesis and bioevaluation of gambogellic acid and its derivatives from gambogic acid as antitumor agents.

Studies on Chemical Modification and Biology of a Natural Product, Gambogic Acid (III): Determination of the Essential Pharmacophore for Biological Activity

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Design, Synthesis and Anti-cancer Evaluation of Nitrogen-containing Derivatives of 30-Carboxyl of Gambogic Acid

Synthesis and Bioevaluation of Gambogic Acid Derivatives as Antitumor Agents

Synthesis and Anti-tumor Activity of Novel Glycyrrhetinic Acid Derivatives

Discovery of a Highly Potent and Novel Gambogic Acid Derivative As an Anticancer Drug Candidate.

Design, Preparation and Studies Regarding Cytotoxic Properties of Glycyrrhetinic Acid Derivatives.

Synthesis and Antitumor Activity of Novel Gibberellin Derivatives with Tetracyclic Diterpenoid Skeletons

Synthesis of Novel Heterocyclic Ring‐Fused 18β‐glycyrrhetinic Acid Derivatives with Antitumor and Antimetastatic Activity

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives

Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives.

Synthesis of glycyrrhetinic acid C3 and C30 derivatives and their antitumor activities in vitro

Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic Acid Derivatives

GA3, a New Gambogic Acid Derivative, Exhibits Potent Antitumor Activities in Vitro Via Apoptosis-Involved Mechanisms